TrialScientific reports2020

Innate T-αβ lymphocytes as new immunological components of anti-tumoral "off-target" effects of the tyrosine kinase inhibitor dasatinib.

Alice Barbarin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.